Genetic Addiction Risk Score (GARS
™
) as a Predictor of Substance Use Disorder: Identifying Predisposition Not Diagnosis
Curr Trends Med Diagn Methods
.
2018;1(1):10.29011/CTMDM-101.100001.
doi: 10.29011/CTMDM-101.100001.
Epub 2018 Sep 11.
Authors
Kenneth Blum
1
2
3
4
5
6
7
,
Lisa Lott
1
,
David Siwicki
1
5
,
Lyle Fried
1
,
Mary Hauser
5
,
Thomas Simpatico
6
,
David Baron
1
2
,
Ahmed Howeedy
7
,
Rajendra D Badgaiyan
1
8
Affiliations
1
Department of Precision Behavioural Research, Geneus Health, San Antonio, TX, USA.
2
Western University Health Sciences, Graduate School of Biomedical Sciences, Pomona, CA, USA.
3
Division of Neurogenetic Research & Addiction Therapy, Florida House Rehabilitati on Centre, Deerfield Beach, FL, USA.
4
Department of Psychology, Eotvos Loránd University, Institute of Psychology, Budapest, Hungary.
5
Division of Addiction Services, Dominion Diagnostics, North Kingstown, Rhode Island, USA.
6
Department of Psychiatry, University of Vermont, Burlington, VT, USA.
7
Division of Neurogenetic & Addiction Therapy Research, The Florida House Experience, Deerfield Beach, FL, USA.
8
Department of Psychiatry, Ichan School of Medicine at Mount Sinai, New York, NY, USA.
PMID:
31276118
PMCID:
PMC6604806
DOI:
10.29011/CTMDM-101.100001
No abstract available
Grants and funding
I01 CX000479/CX/CSRD VA/United States